Bioanalytical Laboratories

 

Phase I / Bioequivalence

About PharmaNet Laboratories

 

Capabilities

Our Equipment

Sample Handling

Method Development and Validation

Sample Analysis

Discovery Support

Biomarkers

ELISA and RIA

ICP / MS

List of Available Assays and Biomarkers

 

About Our Companies

Anapharm

Taylor Technology

Phase I / Bioequivalence

 

About Anapharm

Overview

Phase I Studies

Generic-Drug / Bioequivalence Studies

Services

Experience

Special Populations

Therapeutic Areas

Equipment and Software

Project Management

Quality Assurance

QT / QTc Capabilities

Clinical Laboratory

Clinical Pharmacology

Regulatory / Scientific Affairs

Regulatory / Scientific and Medical Writing

     
     
Consulting   Phase II–IV

Consulting Services

 

Clinical and Product Development

International Regulatory Consultation

Clinical Development Planning

Global Safety and Pharmacovigilance

Risk Management

Gap Analysis

Submission Strategies

Regulatory Liaison

Biostatistics

Pharmacokinetics and Pharmacodynamics

 

Key Product Areas

Biosimilars

Blood

Cell / Gene Therapies

Combination Products

Drug Delivery Systems

Medical Devices

Small Molecule Drug Products

Therapeutic Proteins

Vaccines

 

Business Plan Services

Business Plan Services

 

Life Sciences Investments

Life Sciences Investments

 

Chemistry / Manufacturing Controls

Regulatory Strategies

Implementation Consultation

 

Quality Assurance / Quality Control

SOP Development

FDA Inspection (GxP)

Process Validation

GxP Training / Audits

Quality Systems Regulation

 

Library

Presentations

Case Studies

Conference / Events

Phase II–IV Overview

 

Services

Bioanalytical Laboratory

Biostatistics

Data Management

Global Safety and Pharmacovigilance

Medical Writing

Project Management

Protocol / Case Report Form Design

Quality Control / Assurance

Regulatory Affairs

Risk Management

Site Management

Strategic Planning

Study Monitoring

 

Specialty Areas

Our Approach

Dermatology

General Medicine and Cardiovascular

Infectious Disease and Vaccines

Neuroscience

Oncology

Ophthalmology

Pediatrics

Women's Health

 

Phase IV Development

Phase IV Development

 

Clinical Recruitment

Overview

Program Branding

Effective Database Search

Consistent Study Communications

Study-Specific Web Portal

Professional Referral-Network Mgt

Program-Awareness Materials

Advertising and Public Announcements

Sample List of Deliverables

Additional Programs and Materials

   
   
Technology   Resource Solutions

The Integral Difference of PharmaNet Technology

 

Integral CDMS/CTMS

Integral CDMS / CTMS

 

IVRS

Integrated Voice Response System (IVRS) Overview

Study Supply Management

Randomization

IWRS

Reporting

IVR Diary System

Case Studies

 

EDC

Electronic Data Capture (EDC)

 

Dictionary Coding

Dictionary Coding

 

Laboratory Data Management

Laboratory Data Management

 

Safety Data Management

Safety Data Management

 

PharmaSoft Case Studies

1. Hybrid Data Capture

2. Managing Patient Endpoints

 

Support Service

Support Services

 

In-House Tools

In-House Tools

 

Overview

 

Services

Clients

Candidates

 

Management Team

Management Team

 

Contact Us

Contact Us

 

 

Media Center

Press Releases

Company Overview

Management Biographies

Board Biographies

Office Locations

Corporate Citizenship

Community Outreach

Corporate Responsibility

Events Calendar

Scientific Publications/Media

Information Library

Posters

White Papers

Presentations

Videos

Photo/graphic Library

Executive Photos

Logos

 

 

Careers

Careers

PharmaNet

Anapharm

Taylor Technology

Resource Solutions

About Us

About PharmaNet

Management Team

Company History

Office Locations

 
 
Biologics / Biosimilars   Investigators

Biologics / Biosimilars

 

About Our Relevant Subsidiaries and Partners

Anapharm

PharmaNet

Taylor Technology

Novatia

 

Overview

Overview

 

Services

Analytical Structure Assessments

Cell-based Assay

Consulting

Data Management

ELISA and RIA

Immunogenicity Assay

Pharmacovigilance

Phase I

Phase II / III

Post-Marketing

 

Investigators

Organizations

 

 

Study Participants

Study Participants

 

 

Contact Us

Contact Us
PharmaNet Development Group, Inc.504 Carnegie Center, Princeton, NJ 08540Tel 609 951 6800Fax 609 514 0390